← Leaderboards
Jose Luis Millan
Burnham Institute For Medical Research
$22,480,633
Attributed
$23,596,105
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,596,105 · 10
By mechanism
R01$20,463,046 · 5
P01$1,555,332 · 1
RC1$977,102 · 1
R21$550,625 · 1
R03$50,000 · 2
Top collaborators
- Nicholas David Cosford3 shared
Others in their field
Top investigators on “Alkaline Phosphatase”
- Jay Steven Magaziner · University Of Maryland Baltimore$9,453,328
- Jamey Marth · Sanford Burnham Prebys Medical Discovery Institute$5,437,709
- Xianzhong Meng · University Of Colorado Denver$4,880,392
- Charles K Barlowe · Dartmouth College$4,779,570
- Richard A. Hodin · Beth Israel Deaconess Medical Center$4,722,276
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$4,623,386
Research focus
Alkaline PhosphataseHypophosphatasiaTissuesDiphosphatesExtracellularLeadOsteomalaciaMineralizationCalcificationSkeletalInhibitor/AntagonistMouse ModelBonePreventMediatingIn VivoSkeletonPhysiologic CalcificationOsteoblastsGenesExtracellular MatrixRicketsAffectGenetic
Grant awards (56)
Project 4 - Mechanisms of pyrophosphate dysregulation$426,035
P01 · FY2025 · AG · contact PI
Project 4 - Mechanisms of pyrophosphate dysregulation$444,911
P01 · FY2024 · AG · contact PI
Project 4 - Mechanisms of pyrophosphate dysregulation$684,386
P01 · FY2023 · AG · contact PI
Exploratory Therapy for the Skeletal/Dental Phenotype in PHOSPHO1 Deficiency$241,306
R21 · FY2023 · DE · contact PI
Exploratory Therapy for the Skeletal/Dental Phenotype in PHOSPHO1 Deficiency$309,319
R21 · FY2022 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$580,940
R01 · FY2020 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$580,940
R01 · FY2019 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$580,940
R01 · FY2018 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$658,440
R01 · FY2017 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$682,190
R01 · FY2016 · DE · contact PI
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase$726,119
R01 · FY2015 · AG
Mechanisms of initiation of skeletal mineralization$438,750
R01 · FY2015 · AR · contact PI
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase$752,413
R01 · FY2014 · AG
Mechanisms of initiation of skeletal mineralization$429,975
R01 · FY2014 · AR · contact PI
Lead Optimization of Novel Inhibitors of Tissue Non-specific Alkaline Phosphatase$752,413
R01 · FY2013 · AG
Molecular Pathogenesis and Treatment of Hypophosphatasia$610,423
R01 · FY2013 · DE · contact PI
Mechanisms of initiation of skeletal mineralization$416,813
R01 · FY2013 · AR · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$453,909
R01 · FY2012 · DE · contact PI
Mechanisms of initiation of skeletal mineralization$438,750
R01 · FY2012 · AR · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$196,209
R01 · FY2012 · DE · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$435,616
R01 · FY2011 · DE · contact PI
Mechanisms of initiation of skeletal mineralization$429,750
R01 · FY2011 · AR · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$382,476
R01 · FY2011 · AR · contact PI
Leads and Target Validation for Vascular Calcification in Chronic Kidney Disease$477,232
RC1 · FY2010 · HL · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$449,089
R01 · FY2010 · DE · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$398,413
R01 · FY2010 · AR · contact PI
Mechanisms of initation of skeletal mineralization$327,167
R01 · FY2010 · AR · contact PI
Leads and Target Validation for Vascular Calcification in Chronic Kidney Disease$499,870
RC1 · FY2009 · HL · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$453,625
R01 · FY2009 · DE · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$402,437
R01 · FY2009 · AR · contact PI
Mechanisms of initation of skeletal mineralization$330,148
R01 · FY2009 · AR · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$402,999
R01 · FY2008 · DE · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$402,437
R01 · FY2008 · AR · contact PI
Mechanisms of initation of skeletal mineralization$329,839
R01 · FY2008 · AR · contact PI
The Role of PHOSPHO1 in the Initiation of Skeletal Calcification$25,000
R03 · FY2008 · MH · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$410,650
R01 · FY2007 · AR · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$407,481
R01 · FY2007 · DE · contact PI
Mechanisms of initation of skeletal mineralization$336,270
R01 · FY2007 · AR · contact PI
Activators of the Pyrophosphatase Activity of Alkaline Phosphatase$25,000
R03 · FY2007 · MH · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$419,652
R01 · FY2006 · DE · contact PI
Mechanisms of initation of skeletal mineralization$366,039
R01 · FY2006 · AR · contact PI
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$346,528
R01 · FY2006 · AR · contact PI
Molecular Pathogenesis and Treatment of Hypophosphatasia$429,750
R01 · FY2005 · DE
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$354,868
R01 · FY2005 · AR
Molecular Pathogenesis and Treatment of Hypophosphatasia$429,750
R01 · FY2004 · DE
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$384,605
R01 · FY2004 · AR
MOLECULAR PATHOGENESIS/TREATMENT OF HYPOPHOSPHATASIA$385,043
R01 · FY2003 · DE
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$384,605
R01 · FY2003 · AR
CANCER RELATED PLACENTAL TYPE ALKALINE PHOSPHATASES$341,414
R01 · FY2003 · CA
COUNTER-REGULATORY MECHANISMS IN BONE MINERALIZATION$408,370
R01 · FY2002 · AR
MOLECULAR PATHOGENESIS/TREATMENT OF HYPOPHOSPHATASIA$373,829
R01 · FY2002 · DE
CANCER RELATED PLACENTAL TYPE ALKALINE PHOSPHATASES$317,719
R01 · FY2002 · CA
MOLECULAR PATHOGENESIS/TREATMENT OF HYPOPHOSPHATASIA$362,938
R01 · FY2001 · DE
CANCER RELATED PLACENTAL TYPE ALKALINE PHOSPHATASES$308,467
R01 · FY2001 · CA
MOLECULAR PATHOGENESIS/TREATMENT OF HYPOPHOSPHATASIA$352,365
R01 · FY2000 · DE
CANCER RELATED PLACENTAL TYPE ALKALINE PHOSPHATASES$299,483
R01 · FY2000 · CA